Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tango Therapeutics Q2 EPS $(0.35) Beats $(0.36) Estimate, Sales $3.181M Miss $6.679M Estimate

Author: Benzinga Newsdesk | August 05, 2025 06:05am
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.36) by 3.85 percent. This is a 45.83 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $3.181 million which missed the analyst consensus estimate of $6.679 million by 52.37 percent. This is a 83.99 percent decrease over sales of $19.875 million the same period last year.

Posted In: TNGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist